Condition

Retinitis Pigmentosa (3)

Eye Diseases, Hereditary (1)

PRPF31 Mutationassociated Retinal Dystrophy (1)

RP11 (1)

Retinal Dystrophies (1)

Retinal Dystrophy (1)

Retinal Dystrophy Rod (1)

Retinal Dystrophy Rod Progressive (1)

Retinitis Pigmentosa 11 (1)

Overall Status

Recruiting (3)

Not yet recruiting (1)

Phase

phase 1 (1)

phase 3 (1)

Sponsor

PYC Therapeutics (2)

Johns Hopkins University (1)

Oslo University Hospital (1)

Intervention

clinical examinations (1)

n-acetylcysteine (1)

placebo (1)

vp-001 (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (2)

Observational (2)

PRPF31

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

Recruiting

Retinal Dystrophy
+2 more

VP-001

Dallas, Texas

Retina Foundation of the Southwest

Jun 5, 2023

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting

Retinitis Pigmentosa
+4 more

San Francisco, California
+4 more

Oct 5, 2022

Natural History Study of Retinitis Pigmentosa Type 11

Recruiting

Retinitis Pigmentosa 11
Retinitis Pigmentosa

Clinical examinations

Oslo, Norway

Department of Ophthalmology, Oslo University Hospital

Mar 16, 2021

Retinitis Pigmentosa Trial in Worldwide (N-acetylcysteine, Placebo)

Not yet recruiting

Retinitis Pigmentosa

N-acetylcysteine
Placebo

Davis, California
+30 more

Sep 8, 2022